Active Biotech AB (OSTO:ACTI) OCF Margin %: 0.00% (As of Mar. 2026)


OSTO:ACTI Active Biotech AB OSTO:ACTI
28 GF Score
Price kr5.75
! 1 Warning Sign
View Full Analysis

What is Active Biotech AB OCF Margin %?

Active Biotech AB OSTO:ACTI +2.31% 28 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates OSTO:ACTI with a GF Score™ of 28/100. The stock has 1 warning sign investors should review. Among 959 Biotechnology companies, Active Biotech AB ranks worse than 104275.18% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Active Biotech AB's Cash Flow from Operations for the three months ended in Mar. 2026 was kr-8.00 Mil. Active Biotech AB's Revenue for the three months ended in Mar. 2026 was kr0.00 Mil. Therefore, Active Biotech AB's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Active Biotech AB's current OCF Yield % is -21.13%.

The historical rank and industry rank for Active Biotech AB's OCF Margin % or its related term are showing as below:


During the past 13 years, the highest OCF Margin % of Active Biotech AB was -202.72%. The lowest was -1012.81%. And the median was -384.22%.

OSTO:ACTI's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

Active Biotech AB OCF Margin % Related Terms

Active Biotech AB OCF Margin % Historical Data

* Premium members only.

The historical data trend for Active Biotech AB's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Active Biotech AB OCF Margin % Chart

Active Biotech AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Active Biotech AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:ACTI
28GF Score
Active Biotech AB OSTO:ACTI
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Active Biotech AB OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Active Biotech AB's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-32.399/0
= %

Active Biotech AB's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-8/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Active Biotech AB (OSTO:ACTI) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Active Biotech AB and its competitors. According to the industry distribution chart, Active Biotech AB ranks #999999 out of 959 companies in the Biotechnology industry.
Is Active Biotech AB's OCF Margin % too high?
Active Biotech AB's current OCF Margin % is 0.00%. Based on the distribution chart, Active Biotech AB ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Active Biotech AB has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Active Biotech AB's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Active Biotech AB ranks #999999 out of 959 companies for OCF Margin %. This places Active Biotech AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Active Biotech AB and its competitors. Active Biotech AB's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Active Biotech AB stock overvalued right now?
Active Biotech AB (OSTO:ACTI) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Active Biotech AB's overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Active Biotech AB (OSTO:ACTI), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Active Biotech AB Business Description

Other Exchanges 0GQU:UKBTP:Germany
Address Scheelevagen 22, P.O. Box 724, Lund, SWE, 223 63
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy. Its project portfolio includes both small orally active immunomodulatory molecules and antibody-based immunotherapy. Its pipeline products are: Tasquinimod, Laquinimod, and Naptumomab.
28GF Score

Get the complete analysis for OSTO:ACTI

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr5.75
Price